{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:38:19Z","timestamp":1792420699202,"version":"4.5.0"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00134-024-07737-5","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T09:41:21Z","timestamp":1736242881000},"page":"39-61","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["What intensivists need to know about cytomegalovirus infection in immunocompromised ICU patients"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2912-3357","authenticated-orcid":false,"given":"Sara","family":"Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"7737_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.blre.2015.04.002","volume":"29","author":"E Azoulay","year":"2015","unstructured":"Azoulay E, P\u00e8ne F, Darmon M, Lenglin\u00e9 E, Benoit D, Soares M et al (2015) Managing critically Ill hematology patients: time to think differently. Blood Rev 29:359\u2013367. https:\/\/doi.org\/10.1016\/j.blre.2015.04.002","journal-title":"Blood Rev"},{"key":"7737_CR2","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1001\/jama.2016.16477","volume":"316","author":"R Harpaz","year":"2016","unstructured":"Harpaz R, Dahl RM, Dooling KL (2016) Prevalence of immunosuppression among US adults, 2013. JAMA 316:2547\u20132548. https:\/\/doi.org\/10.1001\/jama.2016.16477","journal-title":"JAMA"},{"key":"7737_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00134-020-06184-2","volume":"47","author":"FG Zampieri","year":"2021","unstructured":"Zampieri FG, Romano TG, Salluh JIF, Taniguchi LU, Mendes PV, Nassar AP et al (2021) Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study. Intensive Care Med 47:170\u2013179. https:\/\/doi.org\/10.1007\/s00134-020-06184-2","journal-title":"Intensive Care Med"},{"key":"7737_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00134-017-5043-2","volume":"44","author":"JL Vincent","year":"2018","unstructured":"Vincent JL, Lefrant JY, Kotfis K, Nanchal R, Martin-Loeches I, Wittebole X et al (2018) Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP). Intensive Care Med 44:337\u2013344. https:\/\/doi.org\/10.1007\/s00134-017-5043-2","journal-title":"Intensive Care Med"},{"key":"7737_CR5","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1111\/ajt.15371","volume":"19","author":"A L\u2019Huillier","year":"2019","unstructured":"L\u2019Huillier A, Ferreira VH, Ku T, Humar A, Bahinskaya I, Kumar D (2019) Improving our mechanistic understanding of the indirect effects of CMV infection in transplant recipients. Am J Transplant 19:2495\u20132504. https:\/\/doi.org\/10.1111\/ajt.15371","journal-title":"Am J Transplant"},{"key":"7737_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s00134-023-07295-2","volume":"50","author":"L Kreitmann","year":"2024","unstructured":"Kreitmann L, Helms J, Martin-Loeches I, Salluh J, Poulakou G, P\u00e8ne F et al (2024) ICU-acquired infections in immunocompromised patients. Intensive Care Med 50:332\u2013349. https:\/\/doi.org\/10.1007\/s00134-023-07295-2","journal-title":"Intensive Care Med"},{"key":"7737_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00134-019-05906-5","volume":"46","author":"E Azoulay","year":"2020","unstructured":"Azoulay E, Russell L, Van de Louw A, Metaxa V, Bauer P, Povoa P et al (2020) Diagnosis of severe respiratory infections in immunocompromised patients. Intensive Care Med 46:298\u2013314. https:\/\/doi.org\/10.1007\/s00134-019-05906-5","journal-title":"Intensive Care Med"},{"key":"7737_CR8","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1007\/s00134-017-4947-1","volume":"43","author":"E Azoulay","year":"2017","unstructured":"Azoulay E, Pickkers P, Soares M, Perner A, Rello J, Bauer PR et al (2017) Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study. Intensive Care Med 43:1808\u20131819. https:\/\/doi.org\/10.1007\/s00134-017-4947-1","journal-title":"Intensive Care Med"},{"key":"7737_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/cid\/ciw668","volume":"64","author":"P Ljungman","year":"2017","unstructured":"Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G et al (2017) Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis 64:87\u201391. https:\/\/doi.org\/10.1093\/cid\/ciw668","journal-title":"Clin Infect Dis"},{"key":"7737_CR10","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/cid\/ciy696","volume":"68","author":"RF Chemaly","year":"2019","unstructured":"Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR et al (2019) Definitions of resistant and refractory cytomegalovirus infection and disease in transplant recipients for use in clinical trials. Clin Infect Dis 68:1420\u20131426. https:\/\/doi.org\/10.1093\/cid\/ciy696","journal-title":"Clin Infect Dis"},{"key":"7737_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-3-540-77349-8_4","volume":"325","author":"C Sinzger","year":"2008","unstructured":"Sinzger C, Digel M, Jahn G (2008) Cytomegalovirus cell tropism. Curr Top Microbiol Immunol 325:63\u201383. https:\/\/doi.org\/10.1007\/978-3-540-77349-8_4","journal-title":"Curr Top Microbiol Immunol"},{"key":"7737_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.chom.2014.02.002","volume":"15","author":"LP Daley-Bauer","year":"2014","unstructured":"Daley-Bauer LP, Roback LJ, Wynn GM, Mocarski ES (2014) Cytomegalovirus hijacks CX3CR1hi patrolling monocytes as immune-privileged vehicles for dissemination in mice. Cell Host Microbe 15:351\u2013362. https:\/\/doi.org\/10.1016\/j.chom.2014.02.002","journal-title":"Cell Host Microbe"},{"key":"7737_CR13","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1097\/ccm.0b013e31819ffea6","volume":"37","author":"L Chiche","year":"2009","unstructured":"Chiche L, Forel JM, Roch A, Guervilly C, Pauly V, Allardet-Servent J et al (2009) Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 37:1850\u20131857. https:\/\/doi.org\/10.1097\/ccm.0b013e31819ffea6","journal-title":"Crit Care Med"},{"key":"7737_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00134-015-4071-z","volume":"42","author":"DSY Ong","year":"2016","unstructured":"Ong DSY, Spitoni C, Klein Klouwenberg PMC, Verduyn Lunel FM, Frencken JF, Schultz MJ et al (2016) Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome. Intensive Care Med 42:333\u2013341. https:\/\/doi.org\/10.1007\/s00134-015-4071-z","journal-title":"Intensive Care Med"},{"key":"7737_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13613-016-0207-8","volume":"6","author":"A Al-Omari","year":"2016","unstructured":"Al-Omari A, Aljamaan F, Alhazzani W, Salih S, Arabi Y (2016) Cytomegalovirus infection in immunocompetent critically ill adults: literature review. Ann Intensive Care 6:110. https:\/\/doi.org\/10.1186\/s13613-016-0207-8","journal-title":"Ann Intensive Care"},{"key":"7737_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jama.300.4.413","volume":"300","author":"AP Limaye","year":"2008","unstructured":"Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ et al (2008) Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 300:413\u2013422. https:\/\/doi.org\/10.1001\/jama.300.4.413","journal-title":"JAMA"},{"key":"7737_CR17","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s00134-022-06716-y","volume":"48","author":"I Gatto","year":"2022","unstructured":"Gatto I, Biagioni E, Coloretti I, Farinelli C, Avoni C, Caciagli V et al (2022) Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. Intensive Care Med 48:706\u2013713. https:\/\/doi.org\/10.1007\/s00134-022-06716-y","journal-title":"Intensive Care Med"},{"key":"7737_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v15112260","volume":"15","author":"V Caciagli","year":"2023","unstructured":"Caciagli V, Coloretti I, Talamonti M, Farinelli C, Gatto I, Biagioni E et al (2023) Association between pulmonary aspergillosis and cytomegalovirus reactivation in critically Ill COVID-19 patients: a prospective observational cohort study. Viruses 15:1\u201311. https:\/\/doi.org\/10.3390\/v15112260","journal-title":"Viruses"},{"key":"7737_CR19","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00134-024-07529-x","volume":"50","author":"LS Boers","year":"2024","unstructured":"Boers LS, FvS G, van Hattem JM, de Brabander J, Zwaan T, van Willigen H et al (2024) Pulmonary herpes simplex virus and cytomegalovirus in patients with acute respiratory distress syndrome related to COVID-19. Intensive Care Med 50:1251\u20131264. https:\/\/doi.org\/10.1007\/s00134-024-07529-x","journal-title":"Intensive Care Med"},{"issue":"8","key":"7737_CR20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00134-024-07562-w","volume":"50","author":"CE Luyt","year":"2024","unstructured":"Luyt CE, Girardis M, Paix\u00e3o P (2024) Herpes simplex virus and cytomegalovirus lung reactivations in severe COVID-19 patients: to treat or not to treat? That is (still) the question. Intensive Care Med 50(8):1317\u20131319. https:\/\/doi.org\/10.1007\/s00134-024-07562-w","journal-title":"Intensive Care Med"},{"issue":"5","key":"7737_CR21","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/v15051165","volume":"15","author":"G Schinas","year":"2023","unstructured":"Schinas G, Moustaka V, Polyzou E, Almyroudi MP, Dimopoulos G, Akinosoglou K (2023) Targeting CMV reactivation to optimize care for critically Ill COVID-19 patients: a review on the therapeutic potential of antiviral treatment. Viruses 15(5):1165. https:\/\/doi.org\/10.3390\/v15051165","journal-title":"Viruses"},{"key":"7737_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00134-015-4066-9","volume":"42","author":"L Papazian","year":"2016","unstructured":"Papazian L, Hraiech S, Lehingue S, Roch A, Chiche L, Wiramus S et al (2016) Cytomegalovirus reactivation in ICU patients. Intensive Care Med 42:28\u201337. https:\/\/doi.org\/10.1007\/s00134-015-4066-9","journal-title":"Intensive Care Med"},{"key":"7737_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3195-5","volume":"18","author":"X Li","year":"2018","unstructured":"Li X, Huang Y, Xu Z, Zhang R, Liu X, Li Y et al (2018) Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis. BMC Infect Dis 18:1\u201310. https:\/\/doi.org\/10.1186\/s12879-018-3195-5","journal-title":"BMC Infect Dis"},{"key":"7737_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc7875","volume":"13","author":"R Osawa","year":"2009","unstructured":"Osawa R, Singh N (2009) Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care 13:1\u201310. https:\/\/doi.org\/10.1186\/cc7875","journal-title":"Crit Care"},{"key":"7737_CR25","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1093\/infdis\/jiz638","volume":"221","author":"H Imlay","year":"2020","unstructured":"Imlay H, Limaye AP (2020) Current understanding of cytomegalovirus reactivation in critical illness. J Infect Dis 221:S94-102. https:\/\/doi.org\/10.1093\/infdis\/jiz638","journal-title":"J Infect Dis"},{"key":"7737_CR26","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1001\/jamainternmed.2017.0895","volume":"177","author":"NJ Cowley","year":"2017","unstructured":"Cowley NJ, Owen A, Shiels SC, Millar J, Woolley R, Ives N et al (2017) Safety and efficacy of antiviral therapy for prevention of cytomegalovirus reactivation in immunocompetent critically ill patients: a randomized clinical trial. JAMA Intern Med 177:774\u2013783. https:\/\/doi.org\/10.1001\/jamainternmed.2017.0895","journal-title":"JAMA Intern Med"},{"key":"7737_CR27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1001\/jama.2017.10569","volume":"318","author":"AP Limaye","year":"2017","unstructured":"Limaye AP, Stapleton RD, Peng L, Gunn SR, Kimball LE, Hyzy R et al (2017) Effect of ganciclovir on IL-6 levels among cytomegalovirus-seropositive adults with critical illness: a randomized clinical trial. JAMA 318:731\u2013740. https:\/\/doi.org\/10.1001\/jama.2017.10569","journal-title":"JAMA"},{"key":"7737_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13613-020-00793-2","volume":"11","author":"L Papazian","year":"2021","unstructured":"Papazian L, Jaber S, Hraiech S, Baumstarck K, Cayot-Constantin S, Aissaoui N et al (2021) Preemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation. Ann Intensive Care 11:33. https:\/\/doi.org\/10.1186\/s13613-020-00793-2","journal-title":"Ann Intensive Care"},{"key":"7737_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2024.154766","volume":"82","author":"A Baber","year":"2024","unstructured":"Baber A, Calvet L, Vissac C, Salmona M, Legoff J, De Jong A et al (2024) Cytomegalovirus infection in intensive care unit patients with hematological malignancies: characteristics and clinical outcomes. J Crit Care 82:154766. https:\/\/doi.org\/10.1016\/j.jcrc.2024.154766","journal-title":"J Crit Care"},{"key":"7737_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jcrc.2021.08.015","volume":"66","author":"F Gonzalez","year":"2021","unstructured":"Gonzalez F, Beschmout S, Chow-chine L, Bisbal M, D\u2019Incan E, Servan L et al (2021) Herpesviridae in critically ill hematology patients: HHV-6 is associated with worse clinical outcome. J Crit Care 66:138\u2013145. https:\/\/doi.org\/10.1016\/j.jcrc.2021.08.015","journal-title":"J Crit Care"},{"key":"7737_CR31","doi-asserted-by":"publisher","first-page":"1070581","DOI":"10.3389\/fpubh.2023.1070581","volume":"11","author":"X Wu","year":"2023","unstructured":"Wu X, Sun T, Cai Y, Zhai T, Liu Y, Gu S et al (2023) Clinical characteristics and outcomes of immunocompromised patients with severe community-acquired pneumonia: a single-center retrospective cohort study. Front Public Health 11:1070581. https:\/\/doi.org\/10.3389\/fpubh.2023.1070581","journal-title":"Front Public Health"},{"issue":"8","key":"7737_CR32","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.idnow.2021.07.005","volume":"51","author":"A Saade","year":"2021","unstructured":"Saade A, Moratelli G, Azoulay E, Darmon M (2021) Herpesvirus reactivation during severe COVID-19 and high rate of immune defect. Infect Dis Now 51(8):676\u2013679. https:\/\/doi.org\/10.1016\/j.idnow.2021.07.005","journal-title":"Infect Dis Now"},{"key":"7737_CR33","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5935\/0103-507x.20170070","volume":"29","author":"SD Rodrigues dos Santos","year":"2018","unstructured":"Rodrigues dos Santos SD, Bafi AT, Rezende de Freitas FG, Pontes de Azevedo LC, Machado FR (2018) Prevalence of cytomegalovirus disease in kidney transplant patients in an intensive care unit. Rev Bras Ter Intens 29:436\u2013443. https:\/\/doi.org\/10.5935\/0103-507x.20170070","journal-title":"Rev Bras Ter Intens"},{"key":"7737_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-024-05029-4","volume":"28","author":"S Fern\u00e1ndez","year":"2024","unstructured":"Fern\u00e1ndez S, Grafia I, Peyrony O, Canet E, Vigneron C, Monet C et al (2024) Clinical characteristics and outcomes of immunocompromised critically ill patients with cytomegalovirus end-organ disease: a multicenter retrospective cohort study. Crit Care 28:1\u201313. https:\/\/doi.org\/10.1186\/s13054-024-05029-4","journal-title":"Crit Care"},{"key":"7737_CR35","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.bbmt.2018.10.011","volume":"25","author":"R Melendez-munoz","year":"2019","unstructured":"Melendez-munoz R, Marchalik R, Jerussi T, Dimitrova D, Nussenblatt V, Beri A et al (2019) Cytomegalovirus infection incidence and risk factors across diverse hematopoietic cell transplantation platforms using a standardized monitoring and treatment approach: a comprehensive evaluation from a single institution. Biol Blood Marrow Transplant 25:577\u2013586. https:\/\/doi.org\/10.1016\/j.bbmt.2018.10.011","journal-title":"Biol Blood Marrow Transplant"},{"key":"7737_CR36","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.bbmt.2016.08.003","volume":"22","author":"M Baker","year":"2016","unstructured":"Baker M, Wang H, Rowley SD, Cai L, Pecora AL, Skarbnik A et al (2016) Comparative outcomes after haploidentical or unrelated donor bone marrow or blood stem cell transplantation in adult patients with hematological malignancies. Biol Blood Marrow Transplant 22:2047\u20132055. https:\/\/doi.org\/10.1016\/j.bbmt.2016.08.003","journal-title":"Biol Blood Marrow Transplant"},{"key":"7737_CR37","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1182\/blood.v99.6.1978","volume":"99","author":"C Junghanss","year":"2002","unstructured":"Junghanss C, Boeckh M, Carter RA, Sandmaier BM, Maris MB, Maloney DG et al (2002) Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. Blood 99:1978\u20131985. https:\/\/doi.org\/10.1182\/blood.v99.6.1978","journal-title":"Blood"},{"key":"7737_CR38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/s2352-3026(15)00289-6","volume":"3","author":"ML Green","year":"2016","unstructured":"Green ML, Leisenring W, Xie H, Mast CT, Cui Y, Sandmaier BM et al (2016) CMV viral load and mortality after hematopoietic cell transplantation: a cohort study in the era of preemptive therapy. Lancet Haematol 3:119\u2013127. https:\/\/doi.org\/10.1016\/s2352-3026(15)00289-6","journal-title":"Lancet Haematol"},{"key":"7737_CR39","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1007\/s00277-020-04201-4","volume":"99","author":"XY Meng","year":"2020","unstructured":"Meng XY, Fu HX, Zhu XL, Wang JZ, Liu X, Yan CH et al (2020) Comparison of different cytomegalovirus diseases following haploidentical hematopoietic stem cell transplantation. Ann Hematol 99:2659\u20132670. https:\/\/doi.org\/10.1007\/s00277-020-04201-4","journal-title":"Ann Hematol"},{"key":"7737_CR40","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/16078454.2021.1905355","volume":"26","author":"T Barlas","year":"2021","unstructured":"Barlas T, \u0130nci K, Aygencel G, T\u00fcrko\u011flu M, Tun\u00e7can \u00d6G, Can F et al (2021) Infections in hematopoietic stem cell transplant patients admitted to hematology intensive care unit: a single-center study. Hematology 26:328\u2013339. https:\/\/doi.org\/10.1080\/16078454.2021.1905355","journal-title":"Hematology"},{"issue":"10","key":"7737_CR41","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1038\/s41409-020-0857-x","volume":"55","author":"C Pichereau","year":"2020","unstructured":"Pichereau C, Lenglin\u00e9 E, Valade S, Michonneau D, Ghrenassia E, Lemiale V et al (2020) Trajectories of acute graft-versus-host disease and mortality in critically ill allogeneic-hematopoietic stem cell recipients: the Allo-GRRR-OH score. Bone Marrow Transplant 55(10):1966\u20131974. https:\/\/doi.org\/10.1038\/s41409-020-0857-x","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"7737_CR42","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/bmt.2015.55","volume":"50","author":"E Lenglin\u00e9","year":"2015","unstructured":"Lenglin\u00e9 E, Chevret S, Moreau AS, P\u00e8ne F, Blot F, Bourhis JH et al (2015) Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 50(6):840\u2013845. https:\/\/doi.org\/10.1038\/bmt.2015.55","journal-title":"Bone Marrow Transplant"},{"key":"7737_CR43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1399-3062.2005.000111.x","volume":"7","author":"F Rossini","year":"2005","unstructured":"Rossini F, Terruzzi E, Cammarota S, Morini F, Fumagalli M, Verga L et al (2005) Cytomegalovirus infection after autologous stem cell transplantation: incidence and outcome in a group of patients undergoing a surveillance program. Transplant Infect Dis 7:122\u2013125. https:\/\/doi.org\/10.1111\/j.1399-3062.2005.000111.x","journal-title":"Transplant Infect Dis"},{"key":"7737_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/hon.2453","volume":"36","author":"F Marchesi","year":"2018","unstructured":"Marchesi F, Pimpinelli F, Ensoli F, Mengarelli A (2018) Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant. Hematol Oncol 36:381\u2013391. https:\/\/doi.org\/10.1002\/hon.2453","journal-title":"Hematol Oncol"},{"key":"7737_CR45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3816\/clm.2006.n.049","volume":"7","author":"SM O\u2019Brien","year":"2006","unstructured":"O\u2019Brien SM, Keating MJ, Mocarski ES (2006) Updated guidelines on the management of cytomegalovirus reactivation on patients with chronic lymphocytic leukemia treated with alemtuzumab. Clin Lymphoma Myeloma 7:125\u2013130. https:\/\/doi.org\/10.3816\/clm.2006.n.049","journal-title":"Clin Lymphoma Myeloma"},{"key":"7737_CR46","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/s1470-2045(16)30671-4","volume":"18","author":"AD Zelenetz","year":"2017","unstructured":"Zelenetz AD, Barrientos JC, Brown JR, Coiffier B, Delgado J, Egyed M et al (2017) Idelalisib or placebo in combination with bendamustine and rituxmiab in patients with relapsed\/refractory CLL\u2014interim results of a phase 3 randomized, double-blind placebo-controlled trial. Lancet Oncol 18:297\u2013311. https:\/\/doi.org\/10.1016\/s1470-2045(16)30671-4","journal-title":"Lancet Oncol"},{"key":"7737_CR47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3109\/10428194.2013.798867","volume":"55","author":"MRJ Tay","year":"2014","unstructured":"Tay MRJ, Lim ST, Tao M, Quek RHH, Tay K, Tan TT (2014) Cytomegalovirus infection and end-organ disease in Asian patients with lymphoma receiving chemotherapy. Leuk Lymphoma 55:182\u2013187. https:\/\/doi.org\/10.3109\/10428194.2013.798867","journal-title":"Leuk Lymphoma"},{"key":"7737_CR48","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1111\/imj.15496","volume":"52","author":"KH Tay","year":"2022","unstructured":"Tay KH, Slavin MA, Thursky KA, Coussement J, Worth LJ, Teh BW et al (2022) Cytomegalovirus DNAemia and disease: current-era epidemiology, clinical characteristics and outcomes in cancer patients other than allogeneic hematopoietic transplantation. Intern Med J 52:1759\u20131767. https:\/\/doi.org\/10.1111\/imj.15496","journal-title":"Intern Med J"},{"key":"7737_CR49","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1164\/rccm.202004-1116tr","volume":"202","author":"A Mirouse","year":"2020","unstructured":"Mirouse A, Vigneron C, Llitjos JF, Chiche JD, Mira JP, Mokart D et al (2020) Sepsis and cancer: an interplay of friends and foes. Am J Respir Crit Care Med 202:1625\u20131635. https:\/\/doi.org\/10.1164\/rccm.202004-1116tr","journal-title":"Am J Respir Crit Care Med"},{"key":"7737_CR50","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13027-015-0039-4","volume":"10","author":"K Schlick","year":"2015","unstructured":"Schlick K, Grundbichler M, Auberger J, Kern JM, Hell M, Hohla F et al (2015) Cytomegalovirus reactivation and its clinical impact in patients with solid tumors. Infect Agent Cancer 10:45. https:\/\/doi.org\/10.1186\/s13027-015-0039-4","journal-title":"Infect Agent Cancer"},{"key":"7737_CR51","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1111\/ajt.12388","volume":"13","author":"O Manuel","year":"2013","unstructured":"Manuel O, Kralidis G, Mueller NJ, Hirsch HH, Garzoni C, Van Delden C et al (2013) Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 13:2402\u20132410. https:\/\/doi.org\/10.1111\/ajt.12388","journal-title":"Am J Transplant"},{"key":"7737_CR52","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1097\/tp.0b013e3181ff1493","volume":"90","author":"A Humar","year":"2010","unstructured":"Humar A, Limaye AP, Blumberg EA, Hauser IA, Vincenti F, Jardine AG et al (2010) Extended valganciclovir prophylaxis in D+\/R\u2212 kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the impact study. Transplantation 90:1427\u20131431. https:\/\/doi.org\/10.1097\/tp.0b013e3181ff1493","journal-title":"Transplantation"},{"key":"7737_CR53","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1086\/324516","volume":"184","author":"RR Razonable","year":"2001","unstructured":"Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G et al (2001) Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis 184:1461\u20131464. https:\/\/doi.org\/10.1086\/324516","journal-title":"J Infect Dis"},{"key":"7737_CR54","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/infdis\/171.4.1014","volume":"171","author":"D Portela","year":"1995","unstructured":"Portela D, Patel R, Larson-Keller JJ, Ilstrup DM, Wiesner RH, Steers JL et al (1995) Okt3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation. J Infect Dis 171:1014\u20131018. https:\/\/doi.org\/10.1093\/infdis\/171.4.1014","journal-title":"J Infect Dis"},{"key":"7737_CR55","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1111\/j.1600-6143.2011.03674.x","volume":"11","author":"DC Brennan","year":"2011","unstructured":"Brennan DC, Legendre C, Patel D, Mange K, Wiland A, Mccague K et al (2011) Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trials. Am J Transplant 11:2453\u20132462. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03674.x","journal-title":"Am J Transplant"},{"key":"7737_CR56","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/j.transproceed.2011.05.007","volume":"43","author":"L Linares","year":"2011","unstructured":"Linares L, Sanclemente G, Cervera C, Hoyo I, Cof\u00e1n F, Ricart MJ et al (2011) Influence of cytomegalovirus disease in outcome of solid organ transplant patients. Transplant Proc 43:2145\u20132148. https:\/\/doi.org\/10.1016\/j.transproceed.2011.05.007","journal-title":"Transplant Proc"},{"key":"7737_CR57","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1016\/j.transproceed.2012.09.023","volume":"44","author":"E Mouloudi","year":"2012","unstructured":"Mouloudi E, Massa E, Georgiadou E, Iosifidis E, Katsika E, Rembelakos G (2012) Infections related to renal transplantation requiring intensive care admission: a 20-year study. Transplant Proc 44:2721\u20132723. https:\/\/doi.org\/10.1016\/j.transproceed.2012.09.023","journal-title":"Transplant Proc"},{"key":"7737_CR58","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1086\/375843","volume":"37","author":"A Erice","year":"2003","unstructured":"Erice A, Tierney C, Hirsch M, Caliendo AM, Weinberg A, Kendall MA et al (2003) Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360). Clin Infect Dis 37:567\u2013578. https:\/\/doi.org\/10.1086\/375843","journal-title":"Clin Infect Dis"},{"key":"7737_CR59","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1186\/s12879-019-4643-6","volume":"19","author":"R Perello","year":"2019","unstructured":"Perello R, Vergara A, Monclus E, Jimenez S, Montero M, Saubi N et al (2019) Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy. BMC Infect Dis 19:1030. https:\/\/doi.org\/10.1186\/s12879-019-4643-6","journal-title":"BMC Infect Dis"},{"key":"7737_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0117466","volume":"10","author":"A Chakraborty","year":"2015","unstructured":"Chakraborty A, Mahapatra T, Mahapatra S, Ansari S, Siddhanta S, Banerjee S et al (2015) Distribution and determinants of cytomegalovirus induced end organ disease\/s among people living with HIV\/AIDS in a poor resource setting: observation from India. PLoS ONE 10:1\u201311. https:\/\/doi.org\/10.1371\/journal.pone.0117466","journal-title":"PLoS ONE"},{"key":"7737_CR61","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/hiv.13115","volume":"22","author":"A Albasanz-Puig","year":"2021","unstructured":"Albasanz-Puig A, Suanzes P, Esperalba J, Fern\u00e1ndez C, Sellar\u00e8s-Nadal J, Torrella A et al (2021) Low frequency of cytomegalovirus (CMV) disease despite high prevalence of CMV viraemia in patients with advanced HIV infection: a clinical and immunological 48-week follow-up study. HIV Med 22:682\u2013689. https:\/\/doi.org\/10.1111\/hiv.13115","journal-title":"HIV Med"},{"key":"7737_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0093702","volume":"9","author":"SH Mayaphi","year":"2014","unstructured":"Mayaphi SH, Brauer M, Morobadi DM, Mazanderani AH, Mafuyeka RT, Olorunju SAS et al (2014) Cytomegalovirus viral load kinetics in patients with HIV\/AIDS admitted to a medical intensive care unit: a case for pre-emptive therapy. PLoS ONE 9:1\u20138. https:\/\/doi.org\/10.1371\/journal.pone.0093702","journal-title":"PLoS ONE"},{"key":"7737_CR63","unstructured":"Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV (2022) Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. Available at https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-andadolescent-opportunistic-infection. Accessed on March 2022"},{"key":"7737_CR64","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/clinids\/22.4.616","volume":"22","author":"I Herry","year":"1996","unstructured":"Herry I, Cadranel J, Antoine M, Meharzi J, Michelson S, Parrot A et al (1996) Cytomegalovirus-induced alveolar hemorrhage in patients with AIDS: a new clinical entity? Clin Infect Dis 22:616\u2013620. https:\/\/doi.org\/10.1093\/clinids\/22.4.616","journal-title":"Clin Infect Dis"},{"key":"7737_CR65","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/rheumatology\/ken231","volume":"47","author":"Y Takizawa","year":"2008","unstructured":"Takizawa Y, Inokuma S, Tanaka Y, Saito K, Atsumi T, Hirakata M et al (2008) Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population. Rheumatology (Oxford) 47:1373\u20131378. https:\/\/doi.org\/10.1093\/rheumatology\/ken231","journal-title":"Rheumatology (Oxford)"},{"key":"7737_CR66","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.55563\/clinexprheumatol\/pqa98i","volume":"39","author":"Y Ota","year":"2021","unstructured":"Ota Y, Kaneko Y, Takeuchi T (2021) Association between mortality and cytomegalovirus reactivation during remission induction therapy in patients with rheumatic diseases. Clin Exp Rheumatol 39:1324\u20131330. https:\/\/doi.org\/10.55563\/clinexprheumatol\/pqa98i","journal-title":"Clin Exp Rheumatol"},{"key":"7737_CR67","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.3760\/cma.j.issn.0376-2491.2016.35.002","volume":"96","author":"L Ren","year":"2016","unstructured":"Ren L, Li Y, Zhang C, Zhao X, Liu X, Li Z (2016) Clinical characteristics and associated risk factors of cytomegalovirus infection in patients with underlying systemic rheumatic diseases. Zhongua Yi Za Zhi 96:2772\u20132776. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2016.35.002","journal-title":"Zhongua Yi Za Zhi"},{"key":"7737_CR68","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1007\/s10067-020-05080-w","volume":"39","author":"Y Shi","year":"2020","unstructured":"Shi Y, Du B, Zhao JL, Qin HY, Hu XY, Jiang W et al (2020) Etiologies and outcomes of rheumatology patients with acute respiratory failure requiring intensive care: a single-center medical records review study of 259 patients. Clin Rheumatol 39:3479\u20133488. https:\/\/doi.org\/10.1007\/s10067-020-05080-w","journal-title":"Clin Rheumatol"},{"key":"7737_CR69","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/ibd.20498","volume":"14","author":"E Dom\u00e8nech","year":"2008","unstructured":"Dom\u00e8nech E, Vega R, Ojanguren I, Hern\u00e1ndez \u00c1, Garcia-Planella E, Bernal I et al (2008) Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis 14:1373\u20131379. https:\/\/doi.org\/10.1002\/ibd.20498","journal-title":"Inflamm Bowel Dis"},{"key":"7737_CR70","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3855\/jidc.17853","volume":"18","author":"MA Tfaily","year":"2024","unstructured":"Tfaily MA, Azzo JD, Gharamti A, Ghanem M, Wazzi-Mkahal R, Kanafani ZA (2024) Risk factors and outcomes of cytomegalovirus infection in the intensive care unit. J Infect Dev Ctries 18:565\u2013570. https:\/\/doi.org\/10.3855\/jidc.17853","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"7737_CR71","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1378\/chest.127.1.233","volume":"127","author":"S Jaber","year":"2005","unstructured":"Jaber S, Chanques G, Borry J, Souche B, Verdier R, Perrigault PF et al (2005) Cytomegalovirus infection in critically ill patients: associated factors and consequences. Chest 127(1):233\u2013241. https:\/\/doi.org\/10.1378\/chest.127.1.233","journal-title":"Chest"},{"key":"7737_CR72","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1056\/nejmoa1910640","volume":"382","author":"SB Drutman","year":"2020","unstructured":"Drutman SB, Mansouri D, Mahdaviani SA, Neehus AL, Hum D, Bryk R et al (2020) Fatal cytomegalovirus infection in an adult with inherited NOS2 deficiency. N Engl J Med 382:437\u2013445. https:\/\/doi.org\/10.1056\/nejmoa1910640","journal-title":"N Engl J Med"},{"issue":"1","key":"7737_CR73","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s10875-021-01162-9","volume":"42","author":"VG Loo","year":"2022","unstructured":"Loo VG, Roussel L, Bernier S, Perez A, Vinh DC (2022) Late-onset combined immunodeficiency with refractory CMV disease due to ICOSL deficiency. J Clin Immunol 42(1):206\u2013209. https:\/\/doi.org\/10.1007\/s10875-021-01162-9","journal-title":"J Clin Immunol"},{"key":"7737_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.815193","volume":"13","author":"S Chan","year":"2022","unstructured":"Chan S, Godsell J, Horton M, Farchione A, Howson LJ, Margetts M et al (2022) Case report: cytomegalovirus disease is an under-recognized contributor to morbidity and mortality in common variable immunodeficiency. Front Immunol 13:1\u201311. https:\/\/doi.org\/10.3389\/fimmu.2022.815193","journal-title":"Front Immunol"},{"key":"7737_CR75","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2214\/ajr.181.4.1811059","volume":"181","author":"T Franquet","year":"2003","unstructured":"Franquet T, Lee KS, M\u00fcller NL (2003) Thin-section CT Findings in 32 Immunocompromised patients with cytomegalovirus pneumonia who do not have AIDS. AJR Am J Roentgenol 181:1059\u20131063. https:\/\/doi.org\/10.2214\/ajr.181.4.1811059","journal-title":"AJR Am J Roentgenol"},{"key":"7737_CR76","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/cid\/civ215","volume":"61","author":"V Erard","year":"2015","unstructured":"Erard V, Guthrie KA, Seo S, Smith J, Huang M, Chien J et al (2015) Reduced mortality of cytomegalovirus pneumonia after hematopoietic cell transplantation due to antiviral therapy and changes in transplantation practices. Clin Infect Dis 61:31\u201339. https:\/\/doi.org\/10.1093\/cid\/civ215","journal-title":"Clin Infect Dis"},{"issue":"9","key":"7737_CR77","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s10096-024-04883-y","volume":"43","author":"B Seybold","year":"2024","unstructured":"Seybold B, Funk T, Dreger P, Egerer G, Brandt J, Mueller-Tidow C et al (2024) Microbiological risk factors, ICU survival, and 1-year survival in hematological patients with pneumonia requiring invasive mechanical ventilation. Eur J Clin Microbiol Infect Dis 43(9):1679\u20131688. https:\/\/doi.org\/10.1007\/s10096-024-04883-y","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"7737_CR78","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1093\/infdis\/jix048","volume":"215","author":"M Boeckh","year":"2017","unstructured":"Boeckh M, Stevens-Ayers T, Travi G, Huang ML, Cheng GS, Xie H et al (2017) Cytomegalovirus (CMV) DNA quantitation in bronchoalveolar lavage fluid from hematopoietic stem cell transplant recipients with CMV pneumonia. J Infect Dis 215:1514\u20131522. https:\/\/doi.org\/10.1093\/infdis\/jix048","journal-title":"J Infect Dis"},{"key":"7737_CR79","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/00000542-199602000-00005","volume":"84","author":"L Papazian","year":"1996","unstructured":"Papazian L, Fraisse A, Garbe L, Zandotti C, Thomas P, Saux P et al (1996) Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia. Anesthesiology 84:280\u2013287. https:\/\/doi.org\/10.1097\/00000542-199602000-00005","journal-title":"Anesthesiology"},{"key":"7737_CR80","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/bmt.2010.35","volume":"45","author":"SM Reddy","year":"2010","unstructured":"Reddy SM, Winston DJ, Territo MC, Schiller GJ (2010) CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency. Bone Marrow Transplant 45:979\u2013984. https:\/\/doi.org\/10.1038\/bmt.2010.35","journal-title":"Bone Marrow Transplant"},{"key":"7737_CR81","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1212\/wnl.43.3_part_1.493","volume":"43","author":"BA Cohen","year":"1993","unstructured":"Cohen BA, McArthur JC, Grohman S, Patterson B, Glass JD (1993) Neurologic prognosis of cytomegalovirus polyradiculomyelopathy in AIDS. Neurology 43:493\u2013499. https:\/\/doi.org\/10.1212\/wnl.43.3_part_1.493","journal-title":"Neurology"},{"key":"7737_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2021.104936","volume":"142","author":"G Handley","year":"2021","unstructured":"Handley G, Pankow S, Bard JD, Yee R, Nigo M, Hasbun R (2021) Distinguishing cytomegalovirus meningoencephalitis from other viral central nervous system infections. J Clin Virol 142:104936. https:\/\/doi.org\/10.1016\/j.jcv.2021.104936","journal-title":"J Clin Virol"},{"issue":"3","key":"7737_CR83","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.diagmicrobio.2013.07.017","volume":"77","author":"A Bhaskaran","year":"2013","unstructured":"Bhaskaran A, Racsa L, Gander R, Southern P, Cavuoti D, Alatoom A (2013) Interpretation of positive molecular tests of common viruses in the cerebrospinal fluid. Diagn Microbiol Infect Dis 77(3):236\u2013240. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.07.017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"7737_CR84","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1016\/j.ejca.2005.07.011","volume":"41","author":"HA Torres","year":"2005","unstructured":"Torres HA, Kontoyiannis DP, Bodey GP, Adachi JA, Luna MA, Tarrand JJ et al (2005) Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer 41:2268\u20132279. https:\/\/doi.org\/10.1016\/j.ejca.2005.07.011","journal-title":"Eur J Cancer"},{"key":"7737_CR85","doi-asserted-by":"publisher","first-page":"8886525","DOI":"10.1155\/2021\/8886525","volume":"2021","author":"P Wetwittayakhlang","year":"2021","unstructured":"Wetwittayakhlang P, Rujeerapaiboon N, Wetwittayakhlung P, Sripongpun P, Pruphetkaew N, Jandee S et al (2021) Clinical features, endoscopic findings, and predictive factors for mortality in tissue-invasive gastrointestinal cytomegalovirus disease between immunocompetent and immunocompromised patients. Gastroenterol Res Pract 2021:8886525. https:\/\/doi.org\/10.1155\/2021\/8886525","journal-title":"Gastroenterol Res Pract"},{"key":"7737_CR86","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.bbmt.2019.07.016","volume":"25","author":"M Su\u00e1rez-Lled\u00f3","year":"2019","unstructured":"Su\u00e1rez-Lled\u00f3 M, Marcos M\u00c1, Cuatrecasas M, Bombi JA, Fern\u00e1ndez-Avil\u00e9s F, Magnano L et al (2019) Quantitative PCR is faster, more objective, and more reliable than immunohistochemistry for the diagnosis of cytomegalovirus gastrointestinal disease in allogeneic stem cell transplantation. Biol Blood Marrow Transplant 25:2281\u20132286. https:\/\/doi.org\/10.1016\/j.bbmt.2019.07.016","journal-title":"Biol Blood Marrow Transplant"},{"key":"7737_CR87","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02861.x","author":"AJ Eid","year":"2010","unstructured":"Eid AJ, Arthurs SK, Deziel J, Razonable RR, Razonable RR (2010) Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02861.x","journal-title":"Am J Transplant"},{"key":"7737_CR88","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00296-017-3693-6","volume":"37","author":"K Ikeda","year":"2017","unstructured":"Ikeda K, Nakajima S, Tanji K, Hirai T, Uomori K, Morimoto S et al (2017) Intestinal perforation due to hemorrhagic cytomegalovirus enteritis in a patient with severe uncontrolled lupus nephritis: a case and review of the literature. Rheumatol Int 37:1395\u20131399. https:\/\/doi.org\/10.1007\/s00296-017-3693-6","journal-title":"Rheumatol Int"},{"key":"7737_CR89","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jcrc.2014.01.003","volume":"29","author":"KS Chan","year":"2013","unstructured":"Chan KS, Yang CC, Chen CM, Yang HH, Lee CC, Chuang YC et al (2013) Cytomegalovirus colitis in intensive care unit patients: Difficulties in clinical diagnosis. J Crit Care 29:474. https:\/\/doi.org\/10.1016\/j.jcrc.2014.01.003","journal-title":"J Crit Care"},{"key":"7737_CR90","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1053\/jlts.2002.36732","volume":"8","author":"D Seehojiet","year":"2002","unstructured":"Seehojiet D, Tullius SG, Christian A, Neumann UYP, Settrnacher U, Miiller AR et al (2002) CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up. Liver Transpl 8:1138\u20131146. https:\/\/doi.org\/10.1053\/jlts.2002.36732","journal-title":"Liver Transpl"},{"key":"7737_CR91","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/jvh.13176","volume":"26","author":"GB McDonald","year":"2019","unstructured":"McDonald GB, Sarmiento JI, Rees-Lui G, Myerson D (2019) Cytomegalovirus hepatitis after bone marrow transplantation: an autopsy study with clinical, histologic and laboratory correlates. J Viral Hepat 26:1344\u20131350. https:\/\/doi.org\/10.1111\/jvh.13176","journal-title":"J Viral Hepat"},{"key":"7737_CR92","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/infdis\/160.5.752","volume":"160","author":"CV Paya","year":"1989","unstructured":"Paya CV, Hermans PE, Wiesner RH, Ludwig J, Smith TF, Rakela J et al (1989) Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis 160:752\u2013758. https:\/\/doi.org\/10.1093\/infdis\/160.5.752","journal-title":"J Infect Dis"},{"key":"7737_CR93","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1399-3062.2007.00241.x","volume":"10","author":"AJ Eid","year":"2008","unstructured":"Eid AJ, Bakri SJ, Kijpittayarit S, Razonable RR (2008) Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transplant Infect Dis 10:13\u201318. https:\/\/doi.org\/10.1111\/j.1399-3062.2007.00241.x","journal-title":"Transplant Infect Dis"},{"key":"7737_CR94","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1086\/318447","volume":"32","author":"F Crippa","year":"2001","unstructured":"Crippa F, Corey L, Chuang EL, Sale G, Boeckh M (2001) Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation. Clin Infect Dis 32:214\u2013219. https:\/\/doi.org\/10.1086\/318447","journal-title":"Clin Infect Dis"},{"key":"7737_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238257","volume":"15","author":"JY Kim","year":"2020","unstructured":"Kim JY, Hong SY, Park WK, Kim RY, Kim M, Park YG et al (2020) Prognostic factors of cytomegalovirus retinitis after hematopoietic stem cell transplantation. PLoS ONE 15:e0238257. https:\/\/doi.org\/10.1371\/journal.pone.0238257","journal-title":"PLoS ONE"},{"key":"7737_CR96","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/s1386-6532(02)00092-6","volume":"25","author":"J Randolph-habecker","year":"2002","unstructured":"Randolph-habecker J, Iwata M, Torok-storb B (2002) Cytomegalovirus mediated myelosuppression. J Clin Virol 25:51\u201356. https:\/\/doi.org\/10.1016\/s1386-6532(02)00092-6","journal-title":"J Clin Virol"},{"key":"7737_CR97","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/j.1600-6143.2009.02607.x","volume":"9","author":"M Drage","year":"2009","unstructured":"Drage M, Reid A, Callaghan CJ, Baber Y, Freeman S, Huguet E et al (2009) Acute cytomegalovirus cholecystitis following renal transplantation. Am J Transplant 9:1249\u20131252. https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02607.x","journal-title":"Am J Transplant"},{"key":"7737_CR98","doi-asserted-by":"publisher","first-page":"12733","DOI":"10.1111\/tid.12733","volume":"19","author":"Y Imaoka","year":"2017","unstructured":"Imaoka Y, Ohira M, Ishiyama K, Ide K, Kobayashi T, Tahara H et al (2017) Perforation of the gallbladder in a patient with acute cytomegalovirus cholecystitis shortly following renal transplantation. Transplant Infect Dis 19:12733. https:\/\/doi.org\/10.1111\/tid.12733","journal-title":"Transplant Infect Dis"},{"key":"7737_CR99","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1097\/00007890-200005150-00042","volume":"69","author":"DK Klassen","year":"2000","unstructured":"Klassen DK, Drachenberg CB, Papadimitriou JC, Cangro CB, Fink JC, Bartlett ST et al (2000) CMV allograft pancreatitis: diagnosis, treatment, and histological features. Transplantation 69:1968\u20131971. https:\/\/doi.org\/10.1097\/00007890-200005150-00042","journal-title":"Transplantation"},{"key":"7737_CR100","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bbmt.2009.05.008","volume":"16","author":"K Kataoka","year":"2010","unstructured":"Kataoka K, Takahashi T, Iwata H, Hangaishi A, Kumano K, Kurokawa M (2010) Fulminant myocarditis after allogeneic bone marrow transplantation: successful cytomegalovirus therapy and mechanical circulatory support for bridge to recovery. Biol Blood Marrow Transplant 16:129\u2013130. https:\/\/doi.org\/10.1016\/j.bbmt.2009.05.008","journal-title":"Biol Blood Marrow Transplant"},{"key":"7737_CR101","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13282","volume":"22","author":"S Scherger","year":"2020","unstructured":"Scherger S, Mathur S, Bajrovic V, Johnson SC, Benamu E, Ramanan P et al (2020) Cytomegalovirus myocarditis in solid organ transplant recipients: a case series and review of literature. Transplant Infect Dis 22:e13282. https:\/\/doi.org\/10.1111\/tid.13282","journal-title":"Transplant Infect Dis"},{"key":"7737_CR102","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13702","volume":"23","author":"KJ Swanson","year":"2021","unstructured":"Swanson KJ, Djamali A, Jorgenson MR, Misch EA, Ghaffar A, Zhong W et al (2021) Cytomegalovirus nephritis in kidney transplant recipients: epidemiology and outcomes of an uncommon diagnosis. Transplant Infect Dis 23:e13702. https:\/\/doi.org\/10.1111\/tid.13702","journal-title":"Transplant Infect Dis"},{"key":"7737_CR103","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/clinids\/16.1.142","volume":"16","author":"DH Spach","year":"1993","unstructured":"Spach DH, Bauwens JE, Myerson D, Mustafa MM, Bowden RA (1993) Cytomegalovirus-induced hemorrhagic cystitis following bone marrow transplantation. Clin Infect Dis 16:142\u2013144. https:\/\/doi.org\/10.1093\/clinids\/16.1.142","journal-title":"Clin Infect Dis"},{"key":"7737_CR104","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1365-2133.2006.07456.x","volume":"155","author":"YL Choi","year":"2006","unstructured":"Choi YL, Kim JA, Jang KT, Kim DS, Kim WS, Lee JH et al (2006) Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients. Br J Dermatol 155:977\u2013982. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07456.x","journal-title":"Br J Dermatol"},{"key":"7737_CR105","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1128\/jvi.79.4.2211-2220.2005","volume":"79","author":"A Rahbar","year":"2005","unstructured":"Rahbar A, S\u00f6derberg-Naucl\u00e9r C (2005) Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation. J Virol 79:2211\u20132220. https:\/\/doi.org\/10.1128\/jvi.79.4.2211-2220.2005","journal-title":"J Virol"},{"key":"7737_CR106","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/tri.12582","volume":"28","author":"A Java","year":"2015","unstructured":"Java A, Edwards A, Rossi A, Pandey R, Gaut J, Delos Santos R et al (2015) Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature. Transplant Int 28:1121\u20131125. https:\/\/doi.org\/10.1111\/tri.12582","journal-title":"Transplant Int"},{"key":"7737_CR107","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/bjh.13837","volume":"172","author":"AM Schram","year":"2016","unstructured":"Schram AM, Comstock P, Campo M, Gorovets D, Mullally A, Bodio K et al (2016) Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years. Br J Haematol 172:412\u2013419. https:\/\/doi.org\/10.1111\/bjh.13837","journal-title":"Br J Haematol"},{"key":"7737_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2022.819465","volume":"9","author":"L\u00c5 Rolsdorph","year":"2022","unstructured":"Rolsdorph L\u00c5, Mosevoll KA, Helgeland L, Reikvam H (2022) Concomitant hemophagocytic lymphohistiocytosis and cytomegalovirus disease: a case based systemic review. Front Med (Lausanne) 9:1\u201314. https:\/\/doi.org\/10.3389\/fmed.2022.819465","journal-title":"Front Med (Lausanne)"},{"key":"7737_CR109","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1146\/annurev-immunol-042617-053206","volume":"36","author":"MM Davis","year":"2018","unstructured":"Davis MM, Brodin P (2018) Rebooting human immunology. Annu Rev Immunol 36:843\u2013864. https:\/\/doi.org\/10.1146\/annurev-immunol-042617-053206","journal-title":"Annu Rev Immunol"},{"key":"7737_CR110","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.bbmt.2010.03.020","volume":"16","author":"N Cantoni","year":"2010","unstructured":"Cantoni N, Hirsch HH, Khanna N, Gerull S, Buser A, Bucher C et al (2010) Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. Biol Blood Marrow Transplant 16:1309\u20131314. https:\/\/doi.org\/10.1016\/j.bbmt.2010.03.020","journal-title":"Biol Blood Marrow Transplant"},{"key":"7737_CR111","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.retram.2019.01.001","volume":"67","author":"A Ghobadi","year":"2019","unstructured":"Ghobadi A, Milton DR, Gowda L, Rondon G, Chemaly RF, Hamdi A et al (2019) HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant HHS public access. Curr Res Transl Med 67:51\u201355. https:\/\/doi.org\/10.1016\/j.retram.2019.01.001","journal-title":"Curr Res Transl Med"},{"key":"7737_CR112","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13483","volume":"23","author":"AD Raval","year":"2021","unstructured":"Raval AD, Kistler KD, Tang Y, Murata Y, Snydman DR (2021) Epidemiology, risk factors, and outcomes associated with CMV in adult kidney transplant recipients: a systematic review of real-world evidence. Transplant Infect Dis 23:e13483. https:\/\/doi.org\/10.1111\/tid.13483","journal-title":"Transplant Infect Dis"},{"key":"7737_CR113","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1111\/ajt.15515","volume":"19","author":"E Gim\u00e9nez","year":"2019","unstructured":"Gim\u00e9nez E, Torres I, Albert E, Pi\u00f1ana JL, Hern\u00e1ndez-Boluda JC, Solano C et al (2019) Cytomegalovirus (CMV) infection and risk of mortality in allogeneic hematopoietic stem cell transplantation (Allo-HSCT): a systematic review, meta-analysis, and meta-regression analysis. Am J Transplant 19:2479\u20132494. https:\/\/doi.org\/10.1111\/ajt.15515","journal-title":"Am J Transplant"},{"key":"7737_CR114","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/nejmoa1706640","volume":"377","author":"FM Marty","year":"2017","unstructured":"Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF et al (2017) Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med 377:2433\u20132444. https:\/\/doi.org\/10.1056\/nejmoa1706640","journal-title":"N Engl J Med"},{"key":"7737_CR115","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.bbmt.2017.07.025","volume":"23","author":"MK Yong","year":"2017","unstructured":"Yong MK, Ananda-Rajah M, Cameron PU, Morrissey CO, Spencer A, Ritchie D et al (2017) Cytomegalovirus reactivation is associated with increased risk of late-onset invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a multicenter study in the current era of viral load monitoring. Biol Blood Marrow Transplant 23:1961\u20131967. https:\/\/doi.org\/10.1016\/j.bbmt.2017.07.025","journal-title":"Biol Blood Marrow Transplant"},{"key":"7737_CR116","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1034\/j.1399-3062.2001.003002070.x","volume":"3","author":"SM Cockfield","year":"2001","unstructured":"Cockfield SM (2001) Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 3:70\u201378. https:\/\/doi.org\/10.1034\/j.1399-3062.2001.003002070.x","journal-title":"Transpl Infect Dis"},{"key":"7737_CR117","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/s0140-6736(04)16500-8","volume":"363","author":"JR Deayton","year":"2004","unstructured":"Deayton JR, Sabin CA, Johnson MA, Emery VC, Wilson P, Griffiths PD (2004) Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet 363:2116\u20132121. https:\/\/doi.org\/10.1016\/s0140-6736(04)16500-8","journal-title":"Lancet"},{"key":"7737_CR118","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/v13020260","volume":"13","author":"F Gugliesi","year":"2021","unstructured":"Gugliesi F, Pasquero S, Griffante G, Scutera S, Albano C, Castillo Pacheco SF et al (2021) Human cytomegalovirus and autoimmune diseases: where are we? Viruses 13:260. https:\/\/doi.org\/10.3390\/v13020260","journal-title":"Viruses"},{"key":"7737_CR119","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jmii.2021.03.005","volume":"55","author":"CW Kuo","year":"2022","unstructured":"Kuo CW, Wang SY, Tsai HP, Su PL, Cia CT, Lai CH et al (2022) Invasive pulmonary aspergillosis is associated with cytomegalovirus viremia in critically ill patients. A retrospective cohort study. J Microbiol Immunol Infect 55:291\u2013299. https:\/\/doi.org\/10.1016\/j.jmii.2021.03.005","journal-title":"J Microbiol Immunol Infect"},{"key":"7737_CR120","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/infdis\/jiab460","volume":"225","author":"R L\u00e9cuyer","year":"2022","unstructured":"L\u00e9cuyer R, Issa N, Tessoulin B, Lavergne RA, Morio F, Gabriel F et al (2022) Epidemiology and clinical impact of respiratory coinfections at diagnosis of pneumocystis jirovecii pneumonia. J Infect Dis 225:868\u2013880. https:\/\/doi.org\/10.1093\/infdis\/jiab460","journal-title":"J Infect Dis"},{"key":"7737_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0296758","volume":"19","author":"A Perret","year":"2024","unstructured":"Perret A, Le Marechal M, Germi R, Maubon D, Garnaud C, Noble J et al (2024) Cytomegalovirus detection is associated with ICU admission in non-AIDS and AIDS patients with Pneumocystis jirovecii pneumonia. PLoS ONE 19:1\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0296758","journal-title":"PLoS ONE"},{"issue":"28","key":"7737_CR122","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000029750","volume":"101","author":"LA Sowah","year":"2022","unstructured":"Sowah LA, George N, Doll M, Chiou C, Bhat P, Smith C et al (2022) Predictors of in-hospital mortality in a cohort of people living with HIV (PLHIV) admitted to an academic medical intensive care unit from 2009 to 2014: a retrospective cohort study. Medicine (Baltimore) 101(28):e29750. https:\/\/doi.org\/10.1097\/md.0000000000029750","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"7737_CR123","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1007\/s00134-014-3481-7","volume":"40","author":"F Barbier","year":"2014","unstructured":"Barbier F, Roux A, Canet E, Martel-Samb P, Aegerter P, Wolff M et al (2014) Temporal trends in critical events complicating HIV infection: 1999\u20132010 multicentre cohort study in France. Intensive Care Med 40(12):1906\u20131915. https:\/\/doi.org\/10.1007\/s00134-014-3481-7","journal-title":"Intensive Care Med"},{"key":"7737_CR124","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/j.1600-6143.2005.00797.x","volume":"5","author":"A Humar","year":"2005","unstructured":"Humar A, Mazzulli T, Moussa G, Razonable RR, Paya CV, Pescovitz D et al (2005) Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+\/R\u2212 transplant recipients. Am J Transplant 5:1065\u20131070. https:\/\/doi.org\/10.1111\/j.1600-6143.2005.00797.x","journal-title":"Am J Transplant"},{"key":"7737_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ctr.13512","volume":"33","author":"RR Razonable","year":"2019","unstructured":"Razonable RR, Humar A (2019) Cytomegalovirus in solid organ transplant recipients\u2014guidelines of the American Society of transplantation infectious diseases community of practice. Clin Transplant 33:1\u201323. https:\/\/doi.org\/10.1111\/ctr.13512","journal-title":"Clin Transplant"},{"key":"7737_CR126","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/cid\/ciab988","volume":"75","author":"RK Avery","year":"2022","unstructured":"Avery RK, Alain S, Alexander BD, Blumberg EA, Chemaly RF, Cordonnier C et al (2022) Maribavir for refractory cytomegalovirus infections with or without resistance post-transplant: results from a phase 3 randomized clinical trial. Clin Infect Dis 75:690\u2013701. https:\/\/doi.org\/10.1093\/cid\/ciab988","journal-title":"Clin Infect Dis"},{"key":"7737_CR127","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s40121-022-00746-1","volume":"12","author":"CN Kotton","year":"2023","unstructured":"Kotton CN, Kamar N (2023) New insights on CMV management in solid organ transplant patients: prevention, treatment, and management of resistant\/refractory disease. Infect Dis Ther 12:333\u2013342. https:\/\/doi.org\/10.1007\/s40121-022-00746-1","journal-title":"Infect Dis Ther"},{"key":"7737_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/tid.13687","volume":"23","author":"KA Linder","year":"2021","unstructured":"Linder KA, Kovacs C, Mullane KM, Wolfe C, Clark NM, La Hoz RM et al (2021) Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients. Transplant Infect Dis 23:1\u20138. https:\/\/doi.org\/10.1111\/tid.13687","journal-title":"Transplant Infect Dis"},{"key":"7737_CR129","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev-med-042921-124739","volume":"74","author":"JL Saullo","year":"2023","unstructured":"Saullo JL, Miller RA (2023) Cytomegalovirus therapy: role of letermovir in prophylaxis and treatment in transplant recipients. Annu Rev Med 74:89\u2013105. https:\/\/doi.org\/10.1146\/annurev-med-042921-124739","journal-title":"Annu Rev Med"},{"key":"7737_CR130","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1016\/s1473-3099(19)30107-0","volume":"19","author":"P Ljungman","year":"2019","unstructured":"Ljungman P, Delacamara R, Robin C, Crocchiolo R, Einsele H, Hill JA et al (2019) Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European conference on infections in leukaemia (ECIL 7). Lancet Infect Dis 19:e260\u2013e272. https:\/\/doi.org\/10.1016\/s1473-3099(19)30107-0","journal-title":"Lancet Infect Dis"},{"key":"7737_CR131","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/s0140-6736(00)02350-3","volume":"355","author":"VC Emery","year":"2000","unstructured":"Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD (2000) Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 355:2032\u20132036. https:\/\/doi.org\/10.1016\/s0140-6736(00)02350-3","journal-title":"Lancet"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-024-07737-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-024-07737-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-024-07737-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T08:44:41Z","timestamp":1738399481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-024-07737-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["7737"],"URL":"https:\/\/doi.org\/10.1007\/s00134-024-07737-5","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SF has received congress registration fee coverage from Pfizer and honoraria for scientific collaboration from Gilead. PC has received honoraria for scientific collaboration from Pfizer, MSD Gilead and AbbVie and has participated in advisory boards (Alexion, Janssen, Sanofi and Gilead). EA has received fees for lectures from Alexion, Sanofi, Pfizer and Gilead. His hospital has received a research grant from Alexion, MSD and a study drug for a trial from Pfizer, not related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}